MicroRNA Dysregulation in the Gastric Carcinogenesis Cascade: Can We Anticipate Its Role in Individualized Care?

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Diogo Miguel Pereira Libânio Monteiro

    Autor

  • Mário Jorge Dinis Ribeiro

    Autor

  • Pedro Filipe Vieira Pimentel Nunes

    Autor

Participantes de fora da FMUP

  • Pita, I
  • Dias, F
  • Teixeira, AL
  • Nogueira, I
  • Medeiros, R.

Unidades de investigação

Abstract

Background: Gastric carcinogenesis progresses from normal mucosa, atrophic/metaplastic gastritis, and dysplasia to adenocarcinoma. MicroRNAs (miRNAs) regulate DNA expression and have been implicated; however, their role is not fully established. Aims: The aim of this study was to characterize plasma and tissue expression of several miRNAs in gastric carcinogenesis stages. Methods: Single-center cross-sectional study in 64 patients: 19 controls (normal mucosa); 15 with extensive atrophic/metaplastic gastritis; and 30 with early gastric neoplasia (EGN). Seven miRNAs (miR-21, miR-146a, miR-181b, miR-370, miR-375, miR 181b, and miR-490) were quantified by real time-qPCR in peripheral blood and endoscopic biopsy samples. Results: We found a significant upregulation of miR-181b, miR-490, and miR-21 in the EGN mucosa (overexpression 2-14-times higher than controls). We observed a significant underexpression of miR-146a and miR-370 in atrophic/metaplastic gastritis (86 and 66% decrease, p = 0.008 and p = 0.001) and in EGN (89 and 62% reduction, p = 0.034 and p = 0.032) compared with controls. There were no differences between lesions and nonneoplastic mucosa and no dysregulation of plasma miRNAs. Conclusion: We found significant dysregulation of 5 miRNAs in gastric carcinogenesis, suggesting a tumor suppressor role for miR-146a and miR-370 and oncogenic potential for miR-21, miR-181, and miR-490. These changes happen diffusely in the gastric mucosa, suggesting a high-risk field defect, which may influence these patients' surveillance.

© 2021 S. Karger AG, Basel.

Dados da publicação

ISSN/ISSNe:
1423-0291, 1015-2008

Pathobiology  S. Karger AG

Tipo:
Article
Páginas:
338-350
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Gastric cancer; Gastric carcinogenesis; Gastric preneoplastic conditions; microRNAs

Financiamento

Proyectos asociados

Individualized gastric adenocarcinoma early diagnosis and improved patients survival: from liquid biopsies to a comprehensive management approach. (IMAGE)

Investigador Principal: Mário Jorge Dinis Ribeiro

Estudo Clínico Académico (IMAGE) . AgênciaD&C . 2021

Effectiveness of endoscopic resection of colonic lesions > 20mm

Investigador Principal: Mário Jorge Dinis Ribeiro

Estudo Clínico Académico (Colonic lesions) . 2020

How endoscopic submucosal dissection for gastrointestinal lesions is being implemented? Results from an international survey

Investigador Principal: Pedro Filipe Vieira Pimentel Nunes

Estudo Clínico Académico (ENDOS) . 2020

Diagnosis and Treatment of Early Gastric Cancer

Investigador Principal: Pedro Filipe Vieira Pimentel Nunes

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação